 1. History or presence of any clinically significant illness, as detected by history, physical examination, andor laboratory tests, that might put the subject at increased risk of adverse events or that might interfere with the absorption, distribution, metabolism, or excretion of study drugs. Clinically significant is defined as being likely to affect the safety of the subject during hisher participation in this trial, or preclude achievement of the protocol objectives. 